Categoría: Geovanny Vicente

TAMPA, Fla., Aug. 7, 2020 /PRNewswire/ — Global Widget, a vertically integrated manufacturer, distributor and marketer of industrial hemp-derived CBD products from its iconic brands Hemp Bombs®, Nature’s Script™ and Perfect Paws Hemp™, announced today the launch of its new white label and raw ingredients division, GWCBD.

With the CBD market expected to exceed a startling $20 billion by 2024 (BDS Analytics), some industry experts think private label is the next frontier for CBD.

«This is a value-add solution that distributors and retailers have been asking for,» said Chad Levitt, Vice President of White Label & Bulk Ingredients for GWCBD. «We’re taking our companywide commitment to compliance, Good Manufacturing Practices, and science-based R&D development — along with everything we have learned from creating our own successful products — and are providing that expertise to white label customers.»

GWCBD offers industrial hemp-derived CBD edibles, topicals, tinctures and pet products, as well as bulk CBD ingredients.

Levitt, who previously served as Chief Commercial Officer for Mile High Labs in Colorado, leads a new GWCBD team consisting of five experienced CBD white label sales specialists. The company currently employs 175 team members working in its three Tampa facilities.

Kevin Collins, co-founder of Global Widget, said the company’s latest white label and raw ingredient offerings have been years in the making.

«Over the last two years, we have built a huge foundation,» Collins said. «We now have a 50,000 square-foot facility for manufacturing with in-house lab testing capabilities. We have a 15,000 square-foot facility for extraction, and another 50,000 square-foot facility for distribution. We’re looking to be the premier supplier and one-stop shop for everything CBD.»

Levitt added: «To see this much vertical integration in one place is what’s really going to set us apart in the market.»

You can learn more about partnering with GWCBD by visiting www.gwcbd.com and following GWCBD on LinkedIn.

About Global Widget:
Global Widget, headquartered in Tampa, Florida, is a vertically integrated manufacturer, distributor and marketer of industrial hemp-derived CBD products, and the powerhouse behind the iconic Hemp Bombs, Nature’s Script and Perfect Paws Hemp brands. Founded in 2016, Global Widget remains committed to revolutionizing the CBD industry through unrivaled transparency, rigorous adherence to current Good Manufacturing Practices and strict compliance standards, and extensive quality control processes — from extraction to finished product. With our 110,000 square feet of facility space and state-of-the-art technology, we are constantly raising the bar on how to deliver the industry’s best CBD experience to wholesalers, retailers and consumers. We provide CBD education and expert marketing support, and offer white label, private label and bulk services. Learn more at www.globalwidget.com.

Media Contact:
Joe Agostinelli, PR Manager
813.497.5752 | mediarelations@globalwidget.com

View original content to download multimedia:http://www.prnewswire.com/news-releases/global-widget-launches-new-cbd-white-label–raw-materials-division-as-a-one-stop-shop-for-everything-cbd-301108079.html

SOURCE Global Widget

July 2020 Hospital ISM^® Report On Business^®

TEMPE, Ariz., Aug. 7, 2020 /PRNewswire/ — Economic activity in the hospital subsector grew in July for the second consecutive month, say the nation’s hospital supply executives in the latest Hospital ISM^® Report On Business^®.

The report was issued today by Nancy LeMaster, MBA, Chair of the Institute for Supply Management^® (ISM^®) Hospital Business Survey Committee: «The Hospital PMI^™ registered 68.9 percent, up 5.3 percentage points from the June reading of 63.6 percent. This was the second month of growth following two months of decline. The Business Activity Index continued to show growth, but at a slower pace than in June. The varying degrees of COVID-19 across the country is impacting levels of elective procedures performed, which affects overall growth and revenues. The Employment Index indicated growth after three months of contraction. The Case Mix Index remained unchanged in July, with a reading of 61.5 percent. The Days Payable Outstanding Index increased 4 percentage points to 55 percent, compared to the June reading of 51 percent. The Technology Spend Index registered 49.5 percent; a decrease of 1 percentage point from the June reading of 50.5 percent.

«Survey Committee members’ comments highlighted disparities in resumption of elective procedures across the country, with some commenting that their facilities were back to 100 percent of historic levels, while others still had not resumed such procedures. There was consensus agreement that personal protective equipment (PPE) shortages continue to be a problem; one panelist’s comment was typical: ‘COVID-19 continues to dominate the current and future availability of PPE and downstream consumable items in the treatment and care for COVID-19 patients,’ » says LeMaster.

About This Report
The information compiled in this report is for the month of July 2020.

The data presented herein is obtained from a survey of hospital supply executives based on information they have collected within their respective organizations. ISM^® makes no representation, other than that stated within this release, regarding the individual company data collection procedures. The data should be compared to all other economic data sources when used in decision-making.

Data and Method of Presentation
The Hospital ISM^® Report On Business^® is based on data compiled from hospital purchasing and supply executives nationwide. Survey responses reflect the change, if any, in the current month compared to the previous month. For each of the indicators measured (Business Activity, New Orders, Employment, Supplier Deliveries, Inventories, Prices, Prices: Pharmaceuticals, Prices: Supplies, Backlog of Orders, New Export Orders, Imports, Inventory Sentiment, Case Mix, Days Payable Outstanding, Technology Spend, and Touchless Orders), this report shows the percentage reporting each response and the diffusion index. Responses represent raw data and are never changed.

The Hospital PMI^™ is a composite index computed from the following, equally weighted indexes: Business Activity, New Orders, Employment and Supplier Deliveries. Diffusion indexes have the properties of leading indicators and are convenient summary measures showing the prevailing direction of change and the scope of change. A Hospital PMI^™ index reading above 50 percent indicates that the hospital sub-sector is generally expanding; below 50 percent indicates that it is generally declining. For the sub-indexes, except Supplier Deliveries, an index reading above 50 percent indicates that the sub-index is generally expanding; below 50 percent indicates that it is generally contracting. A Supplier Deliveries Index above 50 percent indicates slower deliveries and below 50 percent indicates faster deliveries.

The Hospital ISM^® Report On Business^® survey is sent out to the Hospital Business Survey Committee respondents the first part of each month. Respondents are asked to ONLY report on U.S. operations for the current month. ISM^® receives survey responses throughout most of any given month, with the majority of respondents generally waiting until late in the month to submit responses to give the most accurate picture of current business activity. ISM^® then compiles the report for release on the fifth business day of the following month.

ISM ROB Content
The Institute for Supply Management^® («ISM») Report On Business^® (Manufacturing, Services, and Hospital reports) («ISM ROB») contains information, text, files, images, video, sounds, musical works, works of authorship, applications, and any other materials or content (collectively, «Content») of ISM («ISM ROB Content»). ISM ROB Content is protected by copyright, trademark, trade secret, and other laws, and as between you and ISM, ISM owns and retains all rights in the ISM ROB Content. ISM hereby grants you a limited, revocable, nonsublicensable license to access and display on your individual device the ISM ROB Content (excluding any software code) solely for your personal, non-commercial use. The ISM ROB Content shall also contain Content of users and other ISM licensors. Except as provided herein or as explicitly allowed in writing by ISM, you shall not copy, download, stream, capture, reproduce, duplicate, archive, upload, modify, translate, publish, broadcast, transmit, retransmit, distribute, perform, display, sell, or otherwise use any ISM ROB Content.

Except as explicitly and expressly permitted by ISM, you are strictly prohibited from creating works or materials (including, but not limited to: tables, charts, data streams, time-series variables, fonts, icons, link buttons, wallpaper, desktop themes, online postcards, montages, mashups and similar videos, greeting cards, and unlicensed merchandise) that derive from or are based on the ISM ROB Content. This prohibition applies regardless of whether the derivative works or materials are sold, bartered, or given away. You shall not either directly or through the use of any device, software, internet site, web-based service, or other means remove, alter, bypass, avoid, interfere with, or circumvent any copyright, trademark, or other proprietary notices marked on the Content or any digital rights management mechanism, device, or other content protection or access control measure associated with the Content including geo-filtering mechanisms. Without prior written authorization from ISM, you shall not build a business utilizing the Content, whether or not for profit.

You shall not create, recreate, distribute, incorporate in other work, or advertise an index of any portion of the Content unless you receive prior written authorization from ISM. Requests for permission to reproduce or distribute ISM ROB Content can be made by contacting Michelle Rusk in writing at: ISM Research, Institute for Supply Management, 309 W. Elliot Road, Suite 113, Tempe, AZ 85284-1556, or by emailing mrusk@ismworld.org subject: Content Request.

ISM shall not have any liability, duty, or obligation for or relating to the ISM ROB Content or other information contained herein, any errors, inaccuracies, omissions or delays in providing any ISM ROB Content, or for any actions taken in reliance thereon. In no event shall ISM be liable for any special, incidental, or consequential damages, arising out of the use of the ISM ROB. Report On Business^®, PMI^®, NMI^®, Manufacturing PMI^®, Services PMI^™, and Hospital PMI^™ are registered trademarks and trademarks of Institute for Supply Management^®. Institute for Supply Management^® and ISM^® are registered trademarks of Institute for Supply Management, Inc.

About Institute for Supply Management^®
Institute for Supply Management^® (ISM^®) serves supply management professionals in more than 90 countries. Its 50,000 members around the world manage about US$1 trillion in corporate and government supply chain procurement annually. Founded in 1915 as the first supply management institute in the world, ISM is committed to advancing the practice of supply management to drive value and competitive advantage for its members, contributing to a prosperous and sustainable world. ISM leads the profession through the ISM Report On Business^®, its highly regarded certification programs and the ISM Mastery Model^®. This report has been issued by the association since 1931, except for a four-year interruption during World War II.

The full text version of the Hospital ISM^® Report On Business^® is posted on ISM^®‘s website at www.ismrob.org on the fifth business day* of every month at 10:00 a.m. ET.

The next Hospital ISM^® Report On Business^® featuring August 2020 data will be released at 10:00 a.m. ET on Tuesday, September 8, 2020.

*Unless the New York Stock Exchange is closed.

 

 

View original content to download multimedia:http://www.prnewswire.com/news-releases/hospital-pmi-at-68-9-301108147.html

SOURCE Institute for Supply Management

SAN CARLOS, Calif., Aug. 7, 2020 /PRNewswire/ — Natera, Inc. (NASDAQ: NTRA), a pioneer and global leader in cell-free DNA testing, filed suit yesterday against ArcherDX, Inc. for infringement of Natera’s U.S. Patent No. 10,731,220 (the «‘220 Patent»). The complaint was filed in the U.S. District Court of Delaware.

The ‘220 Patent is titled «Methods for Simultaneous Amplification of Target Loci» and was issued by the United States Patent and Trademark Office on August 4, 2020. The ‘220 Patent is one of more than 200 patents issued or pending in Natera’s global intellectual property portfolio, including more than 60 in the field of oncology.

Natera’s complaint alleges that ArcherDX’s sale and use of certain cell-free DNA-based oncology products infringes on the ‘220 Patent. In January of 2020, Natera filed suit in Delaware against ArcherDX (C.A. No. 20-125), asserting four additional patents. Natera is seeking injunctive relief and monetary damages in both cases.

About Natera

Natera is a pioneer and global leader in cell-free DNA testing. The mission of the company is to change the management of disease worldwide with a focus on women’s health, oncology, and organ health. Natera operates an ISO 13485-certified and CAP-accredited laboratory certified under the Clinical Laboratory Improvement Amendments (CLIA) in San Carlos, California. It offers proprietary genetic testing services to inform obstetricians, transplant physicians, oncologists, and cancer researchers, including biopharmaceutical companies, and genetic laboratories through its cloud-based software platform. For more information, visit natera.com. Follow Natera on LinkedIn. 

Forward-Looking Statements

All statements other than statements of historical facts contained in this press release are forward-looking statements and are not a representation that Natera’s plans, estimates, or expectations will be achieved. These forward-looking statements represent Natera’s expectations as of the date of this press release, and Natera disclaims any obligation to update the forward-looking statements. These forward-looking statements are subject to known and unknown risks and uncertainties that may cause actual results to differ materially, including with respect to developments in matters under dispute or litigation, the scope of protection we establish and maintain for, and developments or disputes concerning, our intellectual property or other proprietary rights, our efforts to develop and commercialize new product offerings, and our ability to successfully increase demand for and grow revenues for our product offerings. Additional risks and uncertainties are discussed in greater detail in «Risk Factors» in Natera’s recent filings on Forms 10-K and 10-Q and in other filings Natera makes with the SEC from time to time. These documents are available at www.natera.com/investors and www.sec.gov.

Contacts
Investor Relations: Mike Brophy, CFO, Natera, Inc., 650-249-9090
Media: Paul Greenland, VP of Corporate Marketing, Natera, Inc., pr@natera.com

 

View original content to download multimedia:http://www.prnewswire.com/news-releases/natera-files-additional-suit-against-archerdx-301108279.html

SOURCE Natera, Inc.

PROVO, Utah, Aug. 7, 2020 /PRNewswire/ — Beyond Labz LLC announced today that it has surpassed 200 University and High School customers.  The company was only formed one year ago and has rapidly expanded to support schools’ blended and digital learning requirements for lab sciences. 

«Lab time has always been a precious and scarce commodity,» says Dr Brian Woodfield, Co-Founder of Beyond Labz and its original developer, «but it makes all the difference between learning Science versus just learning about Science.  We want students to explore the classic experiments in science and, as a result, discover the underlying principles following their own path.»

Lab simulations had previously found a firm place in blended programs for student lab prep, or student homework, but the Covid-19 crisis has accelerated their adoption into core lab practical sessions.

Over 200 schools, from the Ivy League to the Pac-12 are using Beyond Labz virtual lab simulations as a lab adjunct to increase capacity and efficiency, with students alternating one week in the virtual labs, and one week in the physical lab, as well as running fully online courses with Beyond Labz simulations substituting for the physical lab. 

«We see blended learning and virtual lab simulations as the new normal,» says Giovanni Tata, Director at Brigham Young University which is both a customer and a minority equity investor in Beyond Labz.  «Schools will look for digital solutions to overcome physical capacity constraints.»

About Beyond Labz

Beyond Labz has developed an open virtual lab engine that delivers the most open and accurate science lab simulations on the market.  Using Beyond Labz simulations, students are free to make the choices and decisions that they would confront in an actual laboratory setting and, in turn, experience the resulting consequences. 

Beyond Labz was founded in May 2019. Its three co-founders bring together a combination of deep education and tech experience and over half the staff have instructional experience.

For more information, go to: https://www.beyondlabz.com.

Media contact:
Jay Raines
+1 630 877 0148
244902@email4pr.com

View original content to download multimedia:http://www.prnewswire.com/news-releases/beyond-labz-surpasses-200-school-installation-milestone-301108008.html

SOURCE Beyond Labz